2023 Induced Pluripotent Stem Cell Market Report: Market Size, Trends, Share Analysis, Share and Industry Forecast To 2032 | Fujifilm Holding Corporation, Thermo Fisher Scientific Inc, Takara Bio Inc, ViaCyte, Fate Therapeutics

As per The Business Research Company's Induced Pluripotent Stem Cell Opportunities And Strategies Market Report 2023, The global induced pluripotent stem cell (iPSC) market reached a value of nearly $2,223.5 million in 2020, having increased at a compound annual growth rate (CAGR) of 9.2% since 2015. The market is expected to grow from $2,223.5 million in 2020 to $3,362.1 million in 2025 at a rate of 8.6%. The induced pluripotent stem cell (iPSC) market is then expected to grow at a CAGR of 6.2% from 2025 and reach $4,547.7 million in 2030.  

Increase in the prevalence of chronic disorders is one of the major factors that is driving the growth of Induced pluripotent stem cell market. Chronic disorders like heart disease, cancer, stroke, diabetes can be treated with Induced pluripotent stem cell. Induced Pluripotent stem cells are taken from any tissues from a child or an adult and are genetically modified to behave like embryonic stem cells. According to the report published by Partnership to Fight Chronic Disorder (PFCD), it was found that out of 133 Million Americans, 45% of the population had at least one chronic disorder. Moreover, it was estimated that 7 out of 10 deaths in the USA, which is approximately 1.7 million, are due to chronic disorders and these deaths can be controlled by induced pluripotent stem cell treatment. This rise in incidences of chronic diseases is expected to drive the demand for induced pluripotent stem cell treatment in the forecast period.

View Complete Report @
https://www.thebusinessresearchcompany.com/report/induced-pluripotent-stem-cell-market

Extensive research is being conducted on the use of induced pluripotent stem cells to treat Parkinson's disease (PD). Parkinson's disease (PD) is a neurodegenerative disorder that affects nerve cells involved in releasing dopamine. The reprogramming of mature cells from skin into induced pluripotent nerve cells which can produce dopamine can be a potential treatment for the Parkinson's disease (PD). In 2018, researchers from Kyoto University, Japan transplanted iPSC's into the brain of patient with Parkinson's disease (PD) which will act as precursors for nerve cells to produce dopamine.
The top opportunities in the induced pluripotent stem cell (iPSC) market segmented by derived cell type will arise in the fibroblasts segment, which will gain $360.1 million of global annual sales by 2025. The top opportunities in the induced pluripotent stem cell (iPSC) market segmented by end-user industry will arise in the hospitals segment, which will gain $393.0 million of global annual sales by 2025. The top opportunities in the induced pluripotent stem cell (iPSC) market segmented by application will arise in the drug discovery and toxicity studies segment, which will gain $520.3 million of global annual sales by 2025. The induced pluripotent stem cell (iPSC) market size will gain the most in the USA at $132.6 million.

Induced Pluripotent Stem Cell Market Segmentation:

The Induced Pluripotent Stem Cell market is segmented by derived cell type, by application, by end-use industry and by geography.

By Derived Cell Type -
The induced pluripotent stem cell (iPSC) market is segmented by derived cell type into
a) Hepatocytes
b) Fibroblasts
c) Keratinocytes
d) Amniotic Cells
e) Others

By Application -
The induced pluripotent stem cell (iPSC) market is segmented by application into
a) Academic Research
b) Drug Discovery And Toxicity Studies
c) Cell & Gene Therapy
d) Regenerative Medicine

By End-User -
The induced pluripotent stem cell (iPSC) market is segmented by end-user into
a) Research Laboratories
b) Hospitals

By Geography- The induced pluripotent stem cell (iPSC) market is segmented by geography into
o Asia Pacific
• China
• Japan
• India
• Australia
• Indonesia
• South Korea

Major players in the Induced Pluripotent Stem Cell market include Fujifilm Holding Corporation, Thermo Fisher Scientific Inc, Takara Bio Inc, ViaCyte, Fate Therapeutics

The regions covered in the global Induced Pluripotent Stem Cell market are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Download FREE SAMPLE Report - https://www.thebusinessresearchcompany.com/sample_request?id=5197&type=smp

The latest report from The Business Research Company, 'Global Induced Pluripotent Stem Cell Opportunities And Strategies Market Report - Forecast To 2032,' provides a comprehensive global perspective with data and statistics from 60+ geographies, analyzing 7000+ market segments. The regional and country breakdowns section offers insights into each geography's market analysis, size, historic and forecast growth, and key strategies for industry competitiveness.

Induced Pluripotent Stem Cell Market Report Table Of Content

1. Executive Summary
2. Table of Contents
3. List of Figures
4. List of Tables
5. Report Structure
……
19. Company Profiles
20. Key Mergers and Acquisitions
21. Opportunities And Strategies
22. Biotechnology Services Market, Conclusions And Recommendations
23. Appendix

PURCHASE the report @
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=5197

Get to know us better:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info

LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/

This release was published on openPR.